These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31966774)

  • 1. Low-expression of
    Liu S; Zhou C; Zhu C; Song Q; Wen M; Liu Y; An H
    Int J Clin Exp Pathol; 2017; 10(8):9035-9041. PubMed ID: 31966774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
    Liu W; Zhao ZY; Shi L; Yuan WD
    Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of miR-136 promotes the progression of osteosarcoma and is associated with the prognosis of patients with osteosarcoma.
    Chu Y; Hu X; Wang G; Wang Z; Wang Y
    Oncol Lett; 2019 Jun; 17(6):5210-5218. PubMed ID: 31186737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-186-5p Functions as a Tumor Suppressor in Human Osteosarcoma by Targeting FOXK1.
    Zhang Z; Zhang W; Mao J; Xu Z; Fan M
    Cell Physiol Biochem; 2019; 52(3):553-564. PubMed ID: 30897321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Expression of microRNA-199b-5p Associates with Poor Prognosis Through Promoting Cell Proliferation, Invasion and Migration Abilities of Human Osteosarcoma.
    Zeng H; Zhang Z; Dai X; Chen Y; Ye J; Jin Z
    Pathol Oncol Res; 2016 Apr; 22(2):253-60. PubMed ID: 26183062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of miR-133a and miR-539 are associated with unfavorable prognosis in patients suffering from osteosarcoma.
    Mirghasemi A; Taheriazam A; Karbasy SH; Torkaman A; Shakeri M; Yahaghi E; Mokarizadeh A
    Cancer Cell Int; 2015; 15():86. PubMed ID: 26388701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
    Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
    Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased microRNA-452 expression and its prognostic significance in human osteosarcoma.
    Li RZ; Wang LM
    World J Surg Oncol; 2016 May; 14():150. PubMed ID: 27193084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of microRNA-605 indicates poor prognosis and promotes the progression of osteosarcoma.
    Yi X; Liu C
    Oncol Lett; 2020 Dec; 20(6):370. PubMed ID: 33154768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression of miR-490-3p in osteosarcoma and its clinical significance.
    Tang B; Liu C; Zhang QM; Ni M
    Eur Rev Med Pharmacol Sci; 2017 Jan; 21(2):246-251. PubMed ID: 28165565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-93 promotes cell proliferation by directly targeting P21 in osteosarcoma cells.
    He Y; Yu B
    Exp Ther Med; 2017 May; 13(5):2003-2011. PubMed ID: 28565800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-199b-5p promotes malignant progression of osteosarcoma by regulating HER2.
    Chen Z; Zhao G; Zhang Y; Ma Y; Ding Y; Xu N
    J BUON; 2018; 23(6):1816-1824. PubMed ID: 30610808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of microRNA152 is associated with the diagnosis and prognosis of patients with osteosarcoma.
    Wang NG; Wang DC; Tan BY; Wang F; Yuan ZN
    Int J Clin Exp Pathol; 2015; 8(8):9314-9. PubMed ID: 26464682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
    Shang Y; Wang LQ; Guo QY; Shi TL
    Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-21 predicts poor prognosis in patients with osteosarcoma.
    Ren X; Shen Y; Zheng S; Liu J; Jiang X
    Br J Biomed Sci; 2016 Oct; 73(4):158-162. PubMed ID: 27922432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-503 is down-regulated in osteosarcoma and suppressed MG63 proliferation and invasion by targeting VEGFA/Rictor.
    Lv T; Liu Y; Li Z; Huang R; Zhang Z; Li J
    Cancer Biomark; 2018; 23(3):315-322. PubMed ID: 30223385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-330-3p Expression Indicates Good Prognosis and Suppresses Cell Proliferation by Targeting Bmi-1 in Osteosarcoma.
    Zheng Z; Bao F; Chen X; Huang H; Zhang X
    Cell Physiol Biochem; 2018; 46(2):442-450. PubMed ID: 29614499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-378 serves as a prognostic biomarker in cholangiocarcinoma and promotes tumor proliferation, migration, and invasion.
    Zhou Z; Ma J
    Cancer Biomark; 2019; 24(2):173-181. PubMed ID: 30594918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miRNA-646 suppresses osteosarcoma cell metastasis by downregulating fibroblast growth factor 2 (FGF2).
    Sun XH; Geng XL; Zhang J; Zhang C
    Tumour Biol; 2015 Mar; 36(3):2127-34. PubMed ID: 25403884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum miR-34a is a potential diagnostic and prognostic marker for osteosarcoma.
    Wang T; Wu J; Liu X; Li S
    Int J Clin Exp Pathol; 2017; 10(9):9683-9689. PubMed ID: 31966849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.